Search Results - "Petesch, B. Pan"

Erasmus syndrome associated with an immune thrombocytopenic purpura by Fouchard, M., Pan Petesch, B., Abasq‐Thomas, C., Saraux, A., Misery, L., Brenaut, E.

Get full text

Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study by Mollard, L.M., Le Mao, R., Tromeur, C., Le Moigne, E., Gouillou, M., Pan-Petesch, B., Delluc, A., Couturaud, F., Lacut, K.

“…Numerous studies have suggested that antipsychotic drugs are associated with an increased risk for a first episode of venous thromboembolism (VTE). However,…”
Get full text

P1031: LOW‐DOSE DOACS IN VERY HIGH‐RISK MYELOPROLIFERATIVE NEOPLASMS: LESS BLEEDING BUT MORE ARTERIAL THROMBOTIC EVENTS by Herbreteau, L., Papageorgiou, L., Le Clech, L., Garcia, G., James, C., Pan‐Petesch, B., Couturaud, F., Lippert, E., Gerotziafas, G., Ianotto, J.‐C.

Get full text

Two novel variants of uncertain significance in GP9 associated with Bernard-Soulier syndrome: Are they true mutations? by Boisseau, P, Debord, C, Eveillard, M, Quéméner, A, Sigaud, M, Giraud, M, Talarmain, P, Thomas, C, Landeau, G, Bezieau, S, Petesch, B Pan, Béné, M C, Fouassier, M

“…Bernard-Soulier syndrome (BSS) is an autosomal recessive major thrombocytopathy, the symptoms of which are mainly marked by mucocutaneous bleeding. This rare…”
Get full text

Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis by Ngo Sack, F., Galinat, H., Egreteau, P.-Y., Mollard, L. M., Fortin, H., Berthou, C., Abgrall, J. F., Pan-Petesch, B.

Get full text

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres by PAN-PETESCH, B., LAGUNA, P., MITAL, A., STANLEY, J., TORCHET, M. F., SALEK, S. Z., SALAJ, P.

“…Several studies have suggested that recombinant factor VIIa (rFVIIa) is effective and safe at doses >90 μg kg−1. In March 2007, the European Medicines Agency…”
Get full text

Haematological parameters associated with postpartum haemorrhage after vaginal delivery: Results from a French cohort study by Salomon, C., de Moreuil, C., Hannigsberg, J., Trémouilhac, C., Drugmanne, G., Gatineau, F., Nowak, E., Anouilh, F., Briend, D., Moigne, E. Le, Merviel, P., Abgrall, JF, Lacut, K., Petesch, B. Pan

“…Immediate postpartum haemorrhage (PPH) is a major, feared and often unpredictable issue. Besides many clinical risk factors, some biological parameters could…”
Get full text

Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine? by de Moreuil, C, Fauchais, A-L, Merviel, P, Tremouilhac, C, Le Moigne, E, Pasquier, E, Pan-Petesch, B, Lacut, K

“…Pre-eclampsia prevention represents a major public health issue, as this vasculo-placental disorder generates a great burden of foeto-maternal morbi-mortality…”
Get full text

P-038: Women’s self-reported experience on LMWH injections for venous thromboembolism prophylaxis during post-partum by Le Moigne, E, Pan-Petesch, B, Tromeur, C, Tremouilhac, C, Jacquot, M, Drugmanne, G, Jolas, S, Alavi, Z, Lacut, K, Mottier, D

Get full text

101 Aquagenic and non-aquagenic pruritus need to be differentiated in MPN: A study of 500 patients by Le Gall-Ianotto, C., Ficheux, A., Lippert, E., Herbreteau, L., b Pan-Petesch, Ianotto, J.

Get full text

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome by Grimaldi-Bensouda, Lamiae, Nordon, Clémentine, Michel, Marc, Viallard, Jean-François, Adoue, Daniel, Magy-Bertrand, Nadine, Durand, Jean-Marc, Quittet, Philippe, Fain, Olivier, Bonnotte, Bernard, Morin, Anne-Sophie, Morel, Nathalie, Costedoat-Chalumeau, Nathalie, Pan-Petesch, Brigitte, Khellaf, Mehdi, Perlat, Antoinette, Sacre, Karim, Lefrere, François, Abenhaim, Lucien, Godeau, Bertrand

“…This prospective observational cohort study aimed to explore the clinical features of incident immune thrombocytopenia in adults and predictors of outcome,…”
Get full text

PB1514 Pre-Delivery Thrombin Generation in Women with Non-Severe Post-Partum Hemorrhage - A Nested Case-Control Study by de Moreuil, C., Pan-Petesch, B., Couturaud, F., Dargaud, Y., Le Roux, L., Schramm, T., Kraemmer, D., Gebhart, J., Ay, C., Pabinger, I.

Get full text

OC 02.4 Women with Severe Postpartum Hemorrhage Have a Decreased Endogenous Thrombin Potential Before Delivery by de Moreuil, C., Dargaud, Y., Nougier, C., Dupré, P., Trémouilhac, C., Le Joliff, D., Rosec, S., Pabinger, I., Ay, C., Couturaud, F., Pan-Petesch, B.

Get full text

PB0638 Final Data from A-MOVE: 12-Month Prospective Multicentre Study to Investigate the Impact of Systematic Joint Examination on Treatment Management Decisions in Patients with Hemophilia A in France by Pan-Petesch, B., Drillaud, N., Chambost, H., Lebreton, A., Valentin, J., Jailler, R., Mahdout, O., Järås, J., Berger, K., Gresko, E., Repessé, Y.

Get full text

OC 02.3 OC 02.3 Risk Factors for Severe Postpartum Hemorrhage after Assisted Reproductive Technology: Data from the French HEMOTHEPP Cohort Study by Robin, S., Bouée, S., Anouilh, F., Trémouilhac, C., Drugmanne, G., Le Guillou, M., Blin, A., Bellec, V., Muller, M., Jacquot, M., Tromeur, C., Couturaud, F., Le Moigne, E., Pan-Petesch, B., de Moreuil, C.

Get full text

OC 60.5 Response to Desmopressin in Type 2N Von Willebrand’s Disease: A Genotype-Phenotype Analysis on a Cohort of 121 Patients by Daniel, M., Rauch, A., Volot, F., Pouymayou, K., Pan-Petesch, B., Castet, S., Itzhar, N., Veyradier, A., Repessé, Y., Ternisien, C., Trossaert, M., Boisseau, P., Jeanpierre, E., Paris, C., Zawadzki, C., Desvages, M., Dupont, A., Goudemand, J., Susen, S.

Get full text

Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma by Duchemin, Jérôme, Pan-Petesch, Brigitte, Arnaud, Bertrand, Blouch, Marie-Thérèse, Abgrall, Jean-François

“…The thrombin generation test is used to study coagulation in patients with haemorrhagic diseases or with high thrombotic risk. To our knowledge, this is the…”
Get more information

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders by Doncarli, Alexandra, Demiguel, Virginie, Canu, Irina Guseva, Goulet, Véronique, Bayart, Sophie, Calvez, Thierry, Castet, Sabine, Dalibard, Vincent, Demay, Yohan, Frotscher, Birgit, Goudemand, Jenny, Lambert, Thierry, Milien, Vanessa, Oudot, Caroline, Sannié, Thomas, Chambost, Hervé

“…FranceCoag is an ongoing open prospective multicentre cohort project aimed at improving epidemiological knowledge about inherited bleeding disorders in France…”
Get full text

PF680 MAJOR OR CLINICALLY RELEVANT NON‐MAJOR HEMORRHAGIC EVENTS IN A LARGE POPULATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA: LOCALIZATION, CONSEQUENCES AND DRUG USE by Nicol, C., Pan‐Petesch, B., Leostic, C., Guillerm, G., Herbreteau, L., Lacut, K., Lippert, E., Ianotto, J.‐C.

“…Background: Polycythemia Vera (PV) and Essential Thrombocythemia (ET), the most common Philadelphia‐negative Myeloproliferative Neoplasms (MPN) are well known…”
Get full text

Efficacité et sécurité de la dapsone dans le purpura thrombopénique immunologique. Résultats d’un essai multicentrique randomisé, contrôle par placebo et d’un essai émulé mono bras dans le registre Carmen by Larue, M., Moulis, G., Rueter, M., Audia, S., Terriou, L., Viallard, J.F., Pan-Petesch, B., Royer, B., Bonnotte, B., Galicier, L., Lambotte, O., Lefrere, F., Cheze, S., Ebbo, M., Mahevas, M., Godeau, B., Michel, M.

Get full text